▲ Israel has launched its fifth vaccination campaign, urging people in risk groups and those over 65 to receive the extra dose that specifically targets the omicron strain of coronavirus, which makes up the majority of cases in the country. In the image, a man receives the biological from Pfizer-BioNTech at Clalit Health, in Tel Aviv.Photo App
Newspaper La Jornada
Thursday, September 29, 2022, p. 14